Purchase Order VA24513P1259
- Not listed
- This is a $3,719.85 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The order is for the company's APLIGRAF advanced wound care product. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $25 million single-award Indefinite Delivery Contract (IDC) with the Department of Veterans Affairs (VA) for next-generation surgical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The $1,239.95 fixed-price delivery order is for the supply of the APLIGRAF wound care product. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, valued at up...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support to Organogenesis Inc., a for-profit manufacturer of advanced regenerative medicine products. The $1,239.95 fixed-price contract is for the supply of the APLIGRAF wound care product, with a period of performance through November 1, 2024. Organogenesis is an established federal contractor, holding several significant Indefinite Delivery Vehicles (IDVs) with the Department of...
- This is a delivery order awarded by the Medical Supply Chain of the Defense Logistics Agency (DLA) to Organogenesis Inc., a leading regenerative medicine company. The order is for $1,239.95 in APLIGRAF wound care products, with a completion date of March 29, 2024. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery Contract (IDC) that Organogenesis holds with the DLA for wound care dressings, discs, and other medical materials. Organogenesis has also...
- This federal contract award is for a delivery order (SPE2DE21D0005|SPE2D625F52FT) with a ceiling value of $1,239.95, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit medical manufacturer headquartered in Canton, Massachusetts. The contract is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration needs across military and veteran healthcare systems. Organogenesis holds several...
- This federal contract award is for the delivery of APLIGRAF, a skin substitute product, to the Department of Defense (DoD) and the Department of Veterans Affairs (VA). The contract, awarded to Organogenesis Inc., a regenerative medicine company, has a ceiling value of $1,239.95 and a completion date of May 23, 2025. It is a Delivery Order contract with a Fixed Price with Economic Price Adjustment pricing type. The contract is not a set-aside. Organogenesis is a key supplier of advanced wound...
- This federal contract award, valued at $2,479.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The delivery order is for APLIGRAF, an advanced wound care product used to support medical treatments for military personnel and veterans. Organogenesis has a strong presence in government medical procurement, holding several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans...
- This is a $1,239.95 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company. The order is for the company's APLIGRAF product, which is a wound dressing and tissue regeneration solution. Organogenesis has been awarded numerous prime federal contracts by the DLA and Department of Veterans Affairs (VA) to provide advanced wound care and surgical products. This specific award is not associated with a set-aside program....
- This federal contract award, valued at $3,719.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care and tissue regeneration products. The award is a Delivery Order under the company's Indefinite Delivery Contract with the DLA, which provides a $49.5 million ceiling for wound care dressings and medical supplies over a five-year period from June 2021 to June 2026. The contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,239.95 fixed-price delivery order is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration for military personnel and veterans. Organogenesis is an established vendor for the Department of Veterans Affairs (VA) and DLA, holding several significant federal...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs (VA) to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is for $3,408.00 to provide APLIGRAF-WOUND COVER, a specialized wound care product. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the VA and Defense Logistics Agency (DLA) for surgical implants, tissue regeneration products, and wound care supplies, demonstrating its strong presence in government medical procurement. The company has a history of providing advanced wound care and regenerative medicine solutions to support military and veteran healthcare systems. This specific contract award does not utilize a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 3/28/13 |